CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC
For the period ended Mar 31, 2024. Filed May 10, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 10, 2024
CELZ$0.62+2.6%Stored close · as of Nov 6, 2026
Contents
Unaudited Condensed Consolidated Balance Sheets
CREATIVE MEDICAL TECHNOLOGY****HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
| March 31, 2024 | December 31, 2023 | |
|---|---|---|
| ASSETS | ||
| CURRENT ASSETS | ||
| Cash | $9,007,398 | $3,466,867 |
| Investments | - | 6,520,191 |
| Inventory | 6,594 | 6,594 |
| Prepaids and other current assets | 190,564 | 277,246 |
| Total Current Assets | 9,204,556 | 10,270,898 |
| OTHER ASSETS | ||
| Other assets | 3,281 | 3,281 |
| Licenses, net of amortization | 411,740 | 441,011 |
| TOTAL ASSETS | $9,619,577 | $10,715,190 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| CURRENT LIABILITIES | ||
| Accounts payable | $336,845 | $317,280 |
| Accrued expenses | 39,920 | 39,920 |
| Advances from related party | 14,194 | 14,194 |
| Total Current Liabilities | 390,959 | 371,394 |
| TOTAL LIABILITIES | 390,959 | 371,394 |
| STOCKHOLDERS' EQUITY | ||
| Common stock, $0.001 par value, 5,000,000 and 50,000,000 shares authorized; 1,431,126 and 1,431,126 issued and 1,354,626 and 1,373,626 outstanding at March 31, 2024 and December 31, 2023, respectively | 1,431 | 1,431 |
| Additional paid-in capital | 69,720,911 | 69,711,749 |
| Accumulated deficit | (60,139,976) | (59,098,432) |
| Treasury stock, at cost, 76,500 and 57,500 shares as of March 31, 2024 and December 31, 2023 | (353,748) | (270,952) |
| TOTAL STOCKHOLDERS' EQUITY | 9,228,618 | 10,343,796 |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| $9,619,577 | $10,715,190 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.